Frequent deletion of ING2 locus at 4q35.1 associates with advanced tumor stage in head and neck squamous cell carcinoma
Authors:
- 8 November 2008
- journal article
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 135 (5) , 703-713
Abstract
Loss of heterozygosity (LOH) in the ING family members has been shown in head and neck squamous cell carcinoma (HNSCC) except for ING2. Like all the other members of ING family, ING2, which is located at chromosome 4q35.1, is a promising tumor suppressor gene (TSG). In this study, we performed LOH analysis of ING2 in HNSCC and compared it with clinicopathological variables. We performed LOH analysis in DNAs from 80 paired of normal and HNSCC tissues, using a specifically designed microsatellite marker on chromosome 4q35.1, which detects allelic loss of ING2. TP53 mutation analysis and its relationship with ING2 chromosomal deletion were also performed in available 68 of the samples. The correlation between LOH status and clinicopathological characteristics was evaluated by using statistical methods. The overall survival (OS) and disease free survival (DFS) were also determined. LOH was detected in 54.6% (30/55) of the informative samples. Statistical significance was obtained between LOH and tumor (T) stage (P = 0.02), application of radiotherapy and chemotherapy. Positive node status (N) appeared to be the only independent prognostic factor for both OS (P = 0.031) and DFS (P = 0.044). Our study showed allelic loss of 4q35.1 in HNSCC. The high percentage of LOH suggests ING2 as a candidate TSG in HNSCC. High LOH frequency was statistically associated with advanced T stage, suggesting that ING2 LOH might occur in late stages during HNSCC progression.Keywords
This publication has 49 references indexed in Scilit:
- Frequent silencing of a putative tumor suppressor gene melatonin receptor 1 A (MTNR1A) in oral squamous‐cell carcinomaCancer Science, 2008
- Genistein sensitizes TRAIL-resistant human gastric adenocarcinoma AGS cells through activation of caspase-3Cancer Letters, 2007
- Identification of homozygous deletions of tumor suppressor gene FAT in oral cancer using CGH-arrayOncogene, 2007
- Identification of a candidate tumor suppressor gene RHOBTB1 located at a novel allelic loss region 10q21 in head and neck cancerJournal of Cancer Research and Clinical Oncology, 2005
- Loss of heterozygosity on chromosome 4q32–35 in sporadic basal cell carcinomas: evidence for the involvement of p33ING2/ING1L and SAP30 genesJournal of Cutaneous Pathology, 2004
- Down-regulation of caspase 3 in breast cancer: a possible mechanism for chemoresistanceOncogene, 2002
- Identification of the small interstitial deletion at chromosome band 1p34–p35 and its association with poor outcome in oligodendroglial tumorsGenes, Chromosomes and Cancer, 2002
- Expression of the novel tumour suppressor p33ING1 is independent of p53British Journal of Cancer, 2000
- TP53 mutations do not correlate with locoregional recurrence in stage I tongue carcinomas.2000
- The candidate tumour suppressor p33ING1cooperates with p53 in cell growth controlNature, 1998